Guy Yeoman was appointed VP Patient Centricity at AstraZeneca in 2015. In this role, he and his team are responsible to enable the delivery patient-driven science across the full lifecycle. He has spent the last eight years with AstraZeneca, the initial two years as the UK Medical Director before moving to Asia to build an integrated medical affairs capability across the Asia Pacific. More recently he established a new global Medical Evidence Centre focused on delivering integrated evidence, external science and publications. Prior to joining AstraZeneca, he spent five years at GlaxoSmithKline in clinical development, medical affairs and project management before moving to develop UK medical affairs and market access for a French company. Guy qualified in Medicine and worked in the NHS in the 1990s.